News
Corline’s IP portfolio further strengthened by EU patent
February 20th, 2012
Corline has secured European IP for application of CHS in Regenerative Medicine, complementing the already approved US and Australian patents.
Corline adds important US and Australian IP within Regenerative Medicine
January 02nd, 2012
Corline Systems AB has been granted approval of two Regenerative Medicine Patent Applications, No. 11/994,457 by the US Intellectual Property Office, and Patent Application No. 2,006,266,501 by Australian Government IP Australia.
Corline’s first Regenerative Medicine patent granted in the US
September 15th, 2011
Swedish company Corline Systems AB, a maker and distributor of its proprietary and unique heparin coating technology for use in Regenerative Medicine, has been granted Patent No. 7981873 by the US Intellectual Property Office.
Corline receives funding from the European Commission
June 07th, 2011
Breakthrough for Corline’s 1.5 MEUR unique Regenerative Medicine Project - receives Funding from the European Commission
Corline signs license agreement
June 26th, 2010
Corline signs exclusive license and supply agreement with major U.S. medical device manufacturer
Additional patent granted to Corline
January 26th, 2010
Canadian authorities grant patent to Corline for use in Regenerative Medicine
